Response and resistance to BET bromodomain inhibitors in triple-negative breast cancerShaokun Shu, Kornélia Polyák, Muhammad B. Ekram et al.|Nature|2016Cited by 629
Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast CancerShaokun Shu, Kornélia Polyák, Hua‐Jun Wu et al.|Molecular Cell|2020Cited by 207
Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targetsDavid S. Johnson, X. Shirley Liu, Wei Li et al.|Genome Research|2008Cited by 129
Comprehensive assessment of estrogen receptor beta antibodies in cancer cell line models and tissue reveals critical limitations in reagent specificityAdam W Nelson, Jason S. Carroll|Molecular and Cellular Endocrinology|2016Cited by 112
<i>EN1</i> Is a Transcriptional Dependency in Triple-Negative Breast Cancer Associated with Brain MetastasisGuillermo Peluffo, Kornélia Polyák, Ashim Subedee et al.|Cancer Research|2019Cited by 68